Home › Leukemia › Massachusetts › Worcester
Leukemia clinical trials in Worcester, MA
3 studies for Leukemia are looking for participants at sites in and around Worcester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Massachusetts, Worcester
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- UMass Chan Medical School, Worcester
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Worcester
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Worcester
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Cancer (all types)7 studies
- Breast Cancer5 studies
- Metastatic Cancer5 studies
- Acute Myeloid Leukemia5 studies
- Schizophrenia5 studies
- Major Depressive Disorder5 studies
- Prostate Cancer5 studies
- Ovarian Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.